FindTrial
Sign In

CRISPR study the mechanism of RSPO\WNT in iver fibrosis

CRISPR study the mechanism of RSPO\WNT in iver fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014941
Enrollment
Unknown
Registered
2018-02-23
Start date
2018-02-23
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver diseases

Interventions

Case series:Case series

Sponsors

The First Hospital of Jiaxing (The First Hospital affliated to Jiaxing College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Liver diseases such as liver cancer, cirrhosis and liver fibrosis were not used within the past 3 months. Male and female aged 18 to 80 years old.

Exclusion criteria

Exclusion criteria: Serious diseases such as heart, lung and liver diseases.

Design outcomes

Primary

MeasureTime frame
Liver disease progress;—

Countries

China

Contacts

Public ContactLinghua Yu

Jiaxing First Hospital (The First Hospital affliated to Jiaxing College)

ylhyqh@hotmail.com+86 13968132538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026